U.S. Banks Stock News

MKS Inc. recently reported first‑quarter 2026 results showing revenue of US$1,078 million and net income of US$84 million, while also affirming guidance for higher second‑quarter revenue and earnings and declaring a US$0.25 per‑share dividend payable on June 12, 2026. At the same time, shareholders approved an expansion of the 2022 Stock Incentive Plan and a lower threshold to call special meetings, underlining governance and incentive structures that could shape how MKS funds growth and...

Wondering if Jefferies Financial Group at around US$52 per share offers good value right now, or if most of the opportunity is already on the table. The stock is down about 1.4% over the past week, up 11.5% over the past month, roughly flat with a 2.0% gain over the last year, and has returned 85.6% over three years and 97.7% over five years. These moves have come alongside ongoing interest in capital markets and financial services companies, with Jefferies often in focus when investors...

Sherwin-Williams (SHW) is back in focus after reporting Q1 2026 sales that exceeded guidance across all three segments, along with fresh data center coating launches and renewed attention from both analysts and institutional investors. See our latest analysis for Sherwin-Williams. Despite Q1 2026 sales outperforming guidance and fresh interest around its data center coatings, Sherwin-Williams’ recent share price momentum has softened, with the stock down 8.7% on a 1 month share price return...

Crescent Energy reported past first-quarter 2026 results with revenue of US$1,182.83 million and a net loss of US$419.85 million, while delivering record average production of 341 MBoe/d. Despite the larger loss, management emphasized record volumes, operational efficiency, and successful integration of newly acquired Permian assets as key drivers of the quarter’s operational outperformance. We’ll now examine how this record production and operational efficiency update affects Crescent...

In its recent past fiscal second quarter update, National Fuel Gas reported a 3% natural gas production decrease at Seneca Resources due to weather-related delays and natural declines, while moving forward with upgrades to its Line N pipeline to carry more Marcellus and Utica shale gas. This combination of softer near-term production and added pipeline capacity highlights how the company is balancing short-term operational challenges with longer-term infrastructure growth in its core...

Lucid Group (NasdaqGS:LCID) is deepening its partnership with Uber, with a US$1.05b capital raise and Uber lifting its stake to 11.5%. Uber has committed to purchase 35,000 Lucid vehicles as part of the agreement, linking Lucid more closely to future autonomous mobility platforms. The news comes as Lucid shifts toward operational turnaround under new CEO Silvio Napoli and addresses a stop sale on its Gravity model tied to supply chain issues. Lucid is also planning a push into more...

The Hanover Insurance Group recently approved a new US$700 million share repurchase authorization and expanded its motorcycle and off-road vehicle insurance offerings into several additional U.S. states, enhancing coverage features and availability. This combination of an enlarged buyback program and broader specialty product footprint highlights the company’s emphasis on capital deployment alongside deeper multi-product relationships with policyholders. We’ll now examine how Hanover’s...

PTC (NasdaqGS:PTC) has expanded its startup program globally, offering early and growth-stage startups in all industries free access to a suite of its professional-grade product development tools. The initiative aims to broaden PTC’s ecosystem and embed its cloud-based PLM and engineering software in emerging businesses worldwide. For investors following PTC, this move sits at the core of what the company does, providing product lifecycle management and engineering software to customers...

Invivyd (IVVD) has released its Q1 2026 numbers with revenue of about US$13.7 million and a basic EPS loss of US$0.13, alongside a trailing 12 month net loss of US$77.6 million. The company has seen revenue move from US$25.4 million in Q4 2024 on a trailing 12 month basis to US$55.9 million in the latest trailing period, while trailing basic EPS has shifted from a loss of US$1.43 to a loss of US$0.35. Investors are therefore looking at a business where top line momentum is meeting still heavy...

Abbott Laboratories (ABT) is drawing fresh scrutiny after sales declines in its Nutrition business, new product launches and pricing moves, and early signs of recovering volumes, all while analysts grow more cautious on the stock. See our latest analysis for Abbott Laboratories. The share price has come under pressure despite the Exact Sciences acquisition and commentary around legal risks. The stock is down 16.83% on a 1 month share price return, and the 1 year total shareholder return has...

Tyra Biosciences, Inc. recently reported first-quarter 2026 results showing a wider net loss of US$39.31 million and basic loss per share of US$0.64, while highlighting progress across three Phase 2 trials for its lead candidate dabogratinib and a cash balance of US$383.5 million supporting operations into the second half of 2028. An interesting angle for investors is how Tyra’s “dabogratinib 3×3” plan concentrates resources on three FGFR3-driven indications, potentially shaping its future...

Humacyte (HUMA) is back in focus after Q1 2026 results highlighted continued losses alongside restructuring moves, new leadership, fresh international agreements, and upcoming clinical readouts that could influence how investors view the stock. See our latest analysis for Humacyte. The share price has been volatile, with a 1 month share price return of 26.36% but a 1 year total shareholder return that is down 58.48%. This reflects shifting sentiment as investors weigh fresh capital raises,...

Rubber Leaf (OTCPK:RLEA) opened 2026 with Q1 revenue of about US$3.3 million and basic EPS of roughly US$0.01, with the stock trading around US$4.50. Over recent periods, the company has seen quarterly revenue range from US$0 to about US$3.3 million while basic EPS has moved between a loss of roughly US$0.01 and a gain of just under US$0.01. This gives investors a clear view of how sensitive margins have been to shifts in activity levels. See our full analysis for Rubber Leaf. With the...

Why Clarivate’s New AI Platform Matters for the Stock Clarivate (CLVT) has launched Web of Science Research Intelligence, an AI-native platform built with research institutions to combine curated data, impact metrics, and workflows across funding, collaboration, and research assessment. For shareholders, this fresh product sits at the heart of Clarivate’s existing research and intellectual property data assets, raising questions about adoption, pricing power, and how it may influence...

Old Dominion Freight Line (ODFL) has drawn fresh attention after reporting quarterly revenue of $1.33b, which declined 2.9% year on year but came in ahead of expectations, alongside accelerating less than truckload volumes and improved yield. See our latest analysis for Old Dominion Freight Line. At a share price of $203.12, Old Dominion Freight Line has delivered a 27.6% year to date share price return and a 19.42% total shareholder return over the past year, with shorter term moves...

In May 2026, Archer-Daniels-Midland reported first-quarter sales of US$20,490 million and net income of US$298 million, modestly above the prior year, raised its full-year adjusted earnings guidance, affirmed a quarterly dividend of US$0.52 per share, and held its annual meeting where all management proposals passed and an environmental reporting proposal was rejected. The earnings beat and guidance increase, underpinned by stronger soybean crush, ethanol and Nutrition margins after U.S...

It's been a pretty great week for KLX Energy Services Holdings, Inc. ( NASDAQ:KLXE ) shareholders, with its shares...

One of the biggest stories of last week was how Gambling.com Group Limited ( NASDAQ:GAMB ) shares plunged 47% in the...

KB Home recently opened several new communities across the U.S., including Stevens Ridge in Marysville, Washington, Sunset Oaks and Madera in Texas, and multiple developments in California and Arizona, offering personalized, ENERGY STAR®-designed homes with prices starting from the mid US$200,000s to the US$590,000s range. These geographically diverse launches, all emphasizing efficiency, health-focused features and extensive buyer personalization, highlight KB Home’s continued push into...

In early May 2026, Open Text Corporation reported third-quarter results showing higher revenue of US$1,282.5 million and net income of US$172.65 million year-on-year, affirmed its 2026 earnings guidance for 1% to 2% revenue growth after adjusting for US$30 million of divested sales, completed the sale of its Vertica business, and confirmed a quarterly dividend of US$0.2750 per share payable on June 19, 2026. By exiting the non-core Vertica analytics unit and directing the proceeds toward...

REalloys (ALOY) has moved into focus after a cluster of filings, including full year 2025 results showing US$0.8 million in sales, a US$75.6 million net loss, and management’s updated view on its going concern status. See our latest analysis for REalloys. Since those filings, REalloys’ share price has come under pressure, with a 7 day share price return down 12.64% and a 30 day share price return down 32.55%. The 1 year total shareholder return is very large, which suggests earlier optimism...

Erasca (ERAS) is under pressure after disclosing that Revolution Medicines accused its lead candidate ERAS-0015 of patent infringement and trade secret misappropriation, prompting multiple securities law investigations and raising fresh questions about the program’s long term prospects. See our latest analysis for Erasca. The latest legal headlines arrive after a sharp 43.79% decline in the 30 day share price return. This follows a strong year to date share price return of 184.96% and a very...

There's been a notable change in appetite for Paysafe Limited ( NYSE:PSFE ) shares in the week since its first-quarter...

In early May 2026, BioCryst Pharmaceuticals reported first-quarter revenue of US$156.41 million but a net loss of US$721.81 million, while maintaining full-year 2026 revenue guidance of US$635 million to US$660 million and announcing a European licensing deal for navenibart that includes a US$70 million upfront payment plus potential milestones and royalties. The navenibart agreement with Neopharmed Gentili’s Irish affiliate both brings immediate capital to BioCryst and outsources European...